AiCuris Gained Bio.NRW Research Promotion
AiCuris GmbH & Co. KG has been awarded a three-year research grant together with the Universities of Bochum, Düsseldorf and Bonn as well as the company Squarix (Marl). This grant is a part of the research promotion program “Bio.NRW” by the Ministry of Innovation, Science and Research of North Rhine-Westphalia. AiCuris will obtain 833,582 Euro.
The project “Innovative Antibiotics made in NRW” is aimed to enable research and development of new antibiotics effective against life threatening multi-resistant bacteria e.g. the hospital agent MRSA (Methicillin-resistant Staphylococcus aureus). The grant is composed from funds of the “Ziel 2 – Programm NRW 2007-20013” (European fund for regional development) and from the Ministry of Innovation, Science and Research of North Rhine-Westphalia.
In its project AiCuris will evaluate the optimisation potential of underexplored natural products together with other members of the consortium. The aim is to identify a development candidate with resistance breaking properties as a new weapon to combat resistant bacteria.
Topics
Organizations
Other news from the department business & finance

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
More news from our other portals
Last viewed contents

Software revolution for clinical trials - Health Tech Start-up Carelane Raises €800,000 in Pre-Seed Funding

First structural map of cystic fibrosis protein sheds light on how mutations cause disease

Carbon fibers from greenhouse gas - How algae could sustainably reduce the carbon dioxide concentration in the atmosphere
AmVac AG Begins Research Cooperation with Bayer - Research Laboratory Inaugurated in Catania

Tattoos could be a risk factor for cancer - Unexpectedly, the area of tattooed body surface turned out not to matter
Researchers identify phosphorylation process vital to cancer growth
Thermo Fisher Scientific Completes Acquisition of Fermentas

Neuromodulation start-up closes EUR 15M Series C financing round - First expandable percutaneous lead for neuromodulation treatment of chronic pain
Sanofi and Regeneron Announce Start of Phase 3 Study of Dupilumab in Patients with Atopic Dermatitis

Development of stretchable and printable free-form lithium-ion batteries - Realization of stretchable, adhesive, and mechanically deformable batteries that effectively transfer ions
